{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:00:46Z","timestamp":1785272446731,"version":"3.55.0"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.transproceed.2026.05.030","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:37:54Z","timestamp":1785271074000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Outcome of Third Myeloablative Allogeneic Stem Cell Transplantation Using Unrelated Cord Blood: A Case Report"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-5040","authenticated-orcid":false,"given":"Jun","family":"Ooi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Konuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2026.05.030_bib0001","first-page":"767","article-title":"Efficacy of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia: results of a systematic review and meta-analysis","volume":"28","author":"Kharfan-Dabaja","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.transproceed.2026.05.030_bib0002","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/10428194.2015.1045900","article-title":"Second allogeneic transplantation using unrelated cord blood for relapsed hematological malignancies after allogeneic transplantation","volume":"57","author":"Konuma","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transproceed.2026.05.030_bib0003","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12185-015-1755-7","article-title":"Third allogeneic stem cell transplantation (SCT) using unrelated cord blood for relapsed acute leukemia after second allogeneic SCT","volume":"101","author":"Konuma","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.transproceed.2026.05.030_bib0004","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jtct.2021.01.025","article-title":"Feasibility and outcomes of a third allogeneic hematopoietic stem cell transplantation: a retrospective analysis from the acute leukemia working party of the European Society for Blood and Marrow Transplantation","volume":"27","author":"Rank","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.transproceed.2026.05.030_bib0005","first-page":"43","article-title":"Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed\/refractory acute leukemia after a second transplantation","volume":"57","author":"Kobayashi","year":"2022","journal-title":"Bone MarrowTransplant"},{"key":"10.1016\/j.transproceed.2026.05.030_bib0006","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1007\/s00277-024-05774-0","article-title":"Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies","volume":"103","author":"Cox","year":"2024","journal-title":"Ann Hematol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526003568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526003568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:37:56Z","timestamp":1785271076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526003568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":6,"alternative-id":["S0041134526003568"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.05.030","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Outcome of Third Myeloablative Allogeneic Stem Cell Transplantation Using Unrelated Cord Blood: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}